Bruno R. Varet

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Journal: HemaSphere

Published: November 26, 2025

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.

Journal: Blood

Published: August 13, 2021

Cryptococcus gattii in Patients with Lymphoid Neoplasms: An Illustration of Evolutive Host-Fungus Interactions.

Cryptococcus gattii in Patients with Lymphoid Neoplasms: An Illustration of Evolutive Host-Fungus Interactions.

Journal: Journal of fungi (Basel, Switzerland)

Published: February 27, 2021

Chronic B-lympho-proliferative disorders

Chronic B-lympho-proliferative disorders

Journal: Presse medicale (Paris, France : 1983)

Published: August 24, 2019

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients.

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 15, 2018

The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism.

The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism.

Journal: Haematologica

Published: January 29, 2018

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.

Journal: Cancer

Published: April 10, 2017

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 18, 2017

Severe chronic primary neutropenia in adults: report on a series of 108 patients.

Severe chronic primary neutropenia in adults: report on a series of 108 patients.

Journal: Blood

Published: March 17, 2015

Reply to J. Richter et al.

Reply to J. Richter et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 30, 2014

Autoimmune neutropenia after kidney transplantation: a disregarded entity of posttransplant neutropenia.

Autoimmune neutropenia after kidney transplantation: a disregarded entity of posttransplant neutropenia.

Journal: Transplantation

Published: March 07, 2014

BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia.

BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 26, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026